LS ARK Genomic Revolution Tracker ETP Securities XS2399368062
2.44
EUR
0.10
EUR
4.25 %
15:44:22
NAV
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 2.77 USD | -0.06 USD | -2.16 % |
|---|
| Vortag | 2.83 USD | Datum | 02.06.2026 |
LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 125.47% | |
| 21Shares Injective Staking ETP | CH1360612134 | 124.07% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 115.83% | |
| 21Shares Artificial Superintelligence Alliance ETP | CH1480821375 | 81.03% | |
| 21Shares Toncoin Staking ETP | CH1297762812 | 71.22% | |
| 21Shares Render ETP | CH1396343266 | 67.90% | |
| 21Shares Bittensor ETP | CH1495416971 | 27.67% | |
| 21Shares Jupiter ETP | CH1480821383 | 18.64% | |
| 21Shares Pendle ETP | CH1495416997 | 10.93% | |
| 21Shares Dogecoin ETP | CH1431521033 | 3.04% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 110.01% | |
| 21shares Canton Network ETP | CH1503127917 | 94.30% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 65.21% | |
| 21shares Morpho ETP | CH1506167027 | 32.15% | |
| 21Shares Toncoin Staking ETP | CH1297762812 | 30.97% | |
| 21Shares Injective Staking ETP | CH1360612134 | 14.23% | |
| 21Shares Jupiter ETP | CH1480821383 | -17.27% | |
| 21Shares Bittensor ETP | CH1495416971 | -18.77% | |
| 21Shares Dogecoin ETP | CH1431521033 | -38.09% | |
| 21Shares XDC Network ETP | CH1464217285 | -39.56% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 16.51% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 6.38% | |
| 21Shares Binance BNB ETP | CH0496454155 | -7.44% | |
| 21Shares Stellar ETP | CH1109575535 | -19.67% | |
| 21Shares Ethereum Core Staking ETP Acc | CH1209763130 | -29.25% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -39.35% | |
| 21Shares Injective Staking ETP | CH1360612134 | -48.51% | |
| 21Shares Dogecoin ETP | CH1431521033 | -54.02% | |
| 21Shares Immutable ETP | CH1360612142 | -74.05% | |
| 21Shares Sui Staking ETP | CH1360612159 | -75.33% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares XRP ETP | CH0454664043 | 125.48% | |
| 21Shares Stellar ETP | CH1109575535 | 103.44% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 56.76% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 14.06% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | -3.33% |
Fundamentaldaten
| Valor | |
| ISIN | XS2399368062 |
| Emittent | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 10.12.2021 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 727’071.13 |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 04.06.2026 |
Anlagepolitik
So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.
ETP Performance: LS ARK Genomic Revolution Tracker ETP Securities
| Performance 1 Jahr | 52.82 | |
| Performance 2 Jahre | 34.21 | |
| Performance 3 Jahre | 0.87 | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |